Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
- To define the clinical response to placebo and two doses of VX-702 in subjects with RA using the number of 20% responses as defined by the American College of Rheumatology (ACR20) at Week 12 by applying the Jonckheere-Terpstra trend analysis - To evaluate the safety and tolerability of 2 dose levels of VX-702 compared to placebo, when administered for 12 weeks to subjects with RA
Critère d'inclusion
- Rheumatoid Arthritis